For example, a study by Falutz et al., New England Journal of Medicine (2010) demonstrated measurable reductions in VAT with Tesamorelin therapy, supporting its clinical efficacy
With more generic pharmaceuticals hitting the market, the glucagon-like peptide 1 (GLP-1) agonists market is expected to develop in the region
It can reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes along with heart and blood vessel disease, according to Medline Plus
Adding a GLP-1 RA can be more complex for those on a multiple daily injection (MDI) insulin regimen (basal + bolus)
On-device, no account required
Comparisons of baseline characteristics between groups were performed using independent-sample t tests or MannWhitney U tests for continuous variables and chi-square or Fishers exact tests for categorical variables